A clinical assessment of the circulating and intracellular availability of precursor molecules, such as Nicotinamide Riboside (NR) or Nicotinamide Mononucleotide (NMN), required for the endogenous synthesis of Nicotinamide Adenine Dinucleotide (NAD+). NAD+ is a vital coenzyme essential for numerous metabolic reactions, DNA repair, and sirtuin activity, all of which are critical for cellular energy and longevity. A favorable status is indicative of robust cellular health and resilience.
Origin
This term is central to the modern biology of aging and metabolism, following the discovery of NAD+’s crucial role in mitochondrial function and its decline with chronological age. Research in sirtuin and PARP enzymes solidified the clinical relevance of maintaining adequate precursor availability. Clinical protocols now aim to optimize this status as a core anti-aging strategy.
Mechanism
NAD+ precursors are absorbed and converted through salvage pathways into NAD+, primarily in the cytoplasm and mitochondria. NAD+ then acts as an electron acceptor and donor in redox reactions, powering the electron transport chain for ATP production, and serving as a substrate for enzymes that regulate gene expression and DNA integrity. Optimizing precursor status ensures the continuous supply of NAD+, thereby supporting cellular energy metabolism and delaying the onset of age-related functional decline.
We use cookies to personalize content and marketing, and to analyze our traffic. This helps us maintain the quality of our free resources. manage your preferences below.
Detailed Cookie Preferences
This helps support our free resources through personalized marketing efforts and promotions.
Analytics cookies help us understand how visitors interact with our website, improving user experience and website performance.
Personalization cookies enable us to customize the content and features of our site based on your interactions, offering a more tailored experience.